Management of metabolic and miscellaneous disorders

Kasprisin, Duke O.; Strauss, Ronald G.; Ciavarella, David; Gilcher, Ronald O.; Kiprov, D; Klein, Harvey G.; McLeod, Bruce C.

doi:10.1002/jca.2920080405

Cited by 5 publications

(3 citation statements)

References 62 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In July of 2013, the American Society for Apheresis (ASFA) published their sixth guidelines on the use of therapeutic apheresis in clinical practice in the Journal of Clinical Apheresis . As with previous editions , the intent of the committee responsible for the guidelines was to provide clear, concise, practical, evidence‐based guidelines for the apheresis practitioner. Such guidance is needed because of the limited quality of the medical literature dealing with therapeutic apheresis.…”

Section: Introductionmentioning

confidence: 99%

American society for apheresis guidelines on the use of apheresis in clinical practice: Practical, concise, evidence‐based recommendations for the apheresis practitioner

Winters

2014

J of Clinical Apheresis

View full text Add to dashboard Cite

The 6th Guidelines on the use of therapeutic apheresis in clinical practice published by the American Society of Apheresis provide practical, concise, and evidence based guidance for the apheresis medicine practitioner. The overall format of the Guidelines has remained unchanged with the 6th edition, compared to the 5th edition, with enhancements in the committee process of creating the guidelines. Because of changes in the writing committee structure, a number of changes have occurred in the ASFA category and recommendation grade for the use of apheresis in the treatment for a number of previously categorized clinical indications. In addition, eight new indications for apheresis, twenty three new clinical situations for previously categorized diseases, and ten new apheresis treatments for previously categorized disorders have been added. The 6th Guidelines continue to be an invaluable resource for those involved in apheresis medicine.

show abstract

Section: Introductionmentioning

confidence: 99%

American society for apheresis guidelines on the use of apheresis in clinical practice: Practical, concise, evidence‐based recommendations for the apheresis practitioner

Winters

2014

J of Clinical Apheresis

View full text Add to dashboard Cite

show abstract

“…To address this shortcoming in the medical literature and to help improve patient care, ASFA has published guidelines in the Journal of Clinical Apheresis on the use of therapeutic apheresis in clinical practice every 3–7 years [3–14, 17–19]. This article provides a brief history of the guidelines published by ASFA, a description of the most recently published guidance, and the future plans for the ASFA guidelines.…”

Section: Introductionmentioning

confidence: 99%

“…In 1993, with Dr. Ron Strauss as editor, the ASFA Clinical Applications Committee of Hemapheresis published the second guidelines [4–9]. Key changes included using roman numerals to identify the categories, revising the definition of category II, splitting the guidelines into multiple documents, and expanding the number of diseases evaluated to 53.…”

Section: Introductionmentioning

confidence: 99%

Apheresis medicine state of the art in 2010: American Society for Apheresis fifth special edition of the Journal of Clinical Apheresis

Winters¹

2011

J of Clinical Apheresis

View full text Add to dashboard Cite

The quality of evidence supporting the use of apheresis in the treatment of individual diseases and disorders is often limited. For most diseases and disorders, randomized controlled trials of the use of apheresis have not been performed and for many, due to rarity of the condition, it is unlikely that they will ever be performed. In keeping with its vision, the American Society for Apheresis (ASFA) has created and regularly updated guidelines on the use of apheresis in the treatment of disease. These guidelines seek to summarize the literature on the use of apheresis in treating diseases, provide a critical review of this literature, and give practical guidance to apheresis practitioners. The most recent ASFA guidelines were published in 2010. This article reviews the history of the ASFA guidelines, the changes that were made in the 2010 guidelines, and future directions and plans for these guidelines. The 2010 ASFA guidelines on the use of therapeutic apheresis in clinical practice represent the state of the art in apheresis medicine in 2010.

show abstract

Therapeutic Plasma Exchange

Andrzejewski

2001

Handbook of Transfusion Medicine

View full text Add to dashboard Cite

Management of metabolic and miscellaneous disorders

Cited by 5 publications

References 62 publications

American society for apheresis guidelines on the use of apheresis in clinical practice: Practical, concise, evidence‐based recommendations for the apheresis practitioner

American society for apheresis guidelines on the use of apheresis in clinical practice: Practical, concise, evidence‐based recommendations for the apheresis practitioner

Apheresis medicine state of the art in 2010: American Society for Apheresis fifth special edition of the Journal of Clinical Apheresis

Therapeutic Plasma Exchange

Contact Info

Product

Resources

About